Tempest Therapeutics, Inc. (TPST) Financial Ratios
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
TPST stock: frequently asked questions
What is TPST's ST Score?
Tempest Therapeutics, Inc. (TPST) has an ST Score of 32.6 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is TPST a buy, hold, or sell?
Analysts rate TPST a Buy. Our ST Score grades it C- (32.6/100). The ST Score is a data-driven signal, not a recommendation.
What are TPST's factor grades?
Valuation B-, Profitability F, Financial Strength C-, Momentum D, Growth A-.
What is TPST's valuation grade?
Tempest Therapeutics, Inc. (TPST) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is TPST's growth grade?
Tempest Therapeutics, Inc. (TPST) earns a growth grade of A-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is TPST's profitability grade?
Tempest Therapeutics, Inc. (TPST) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is TPST's financial strength grade?
Tempest Therapeutics, Inc. (TPST) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is TPST's Piotroski score?
Tempest Therapeutics, Inc. (TPST) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.